Puma Biotechnology (PBYI) Stock Price, Quote, News & History | Benzinga

SPY772.10−0.66%QQQ745.92−1.56%BTC/USD80,882.93−2.87%DIA510.91−0.02%GLD378.46+0.69%TLT77.77+0.81%

Puma Biotechnology Inc (PBYI) Stock Price, Quote, News & History

PBYINASDAQ

Trade with Public

Trade with Public

$9.92

0.111.12%

Last update: Oct 8, 2:04 PM

$9.81

N/A

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$9.75

Close

-

Volume / Avg.

141.49K / 328.24K

Day Range

$9.45 - $9.94

52 Wk Range

4.58 - 10.10

Market Cap

$512.07M

P/E Ratio

19.27

Dividend Yield

-

Exchange

NASDAQ

RSI

60

Short Interest

9.8%

Days to Cover

13.8

Recent Puma Biotechnology Inc News

Pfizer Wins $107.5M Verdict Against AstraZeneca Over Cancer Drug Patent Dispute

A Delaware jury ordered AstraZeneca to pay Pfizer $107.5 million, ruling that AstraZeneca's lung cancer drug Tagrisso infringed on Pfizer's patents related to cancer treatment.

Vandana Singh

Puma Biotechnology's Q1 Earnings and Revenues Beat

Puma Biotechnology, Inc. (NASDAQ: PBYI) reported first-quarter 2024 adjusted loss of 5 cents per share, which was narrower than the Zacks Consensus Estimate of a loss of 16 cents. In the year-ago quarter, the company had reported adjusted earnings of 9 cents.

Zacks

Why Nanobiotix Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket

Gainers Lytus Technologies Holdings PTV. Ltd. (NASDAQ: LYT) shares surged 39.3% to $0.6621 in pre-market trading after gaining around 14% on Wednesday.

Lisa Levin

Why Bed Bath & Beyond Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Gainers SCYNEXIS, Inc. (NASDAQ: SCYX) shares climbed 68% to $2.8184 after the company announced an exclusive license agreement with GSK for Brexafemme, in which the company will receive an upfront payment of $90 million.

Lisa Levin

Why Puma Biotechnology Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Gainers ObsEva SA (NASDAQ: OBSV) surged 86.6% to $0.1978 after dropping over 12% on Thursday. ObsEva recently announced strategic reorganization to consolidate operations in Switzerland.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

41.15M

Investing Cash Flow (TTM)

-16.02M

Financing Cash Flow (TTM)

-45.34M

Free Cash Flow (TTM)

41.16M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

-20.22M

Analyst Trends and Forecast

0

0

0

0

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.5

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$418.34M

PE Ratio (TTM)

19.27

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

2.20

PB Ratio (TTM)

3.66

Earnings Yield % (TTM)

5.19%

Earnings Yield % (FWD)

-

EV / EBITDA (TTM)

9.26

Price / EBITDA (TTM)

11.27

Price / Free Cash Flow (TTM)

12.37

Book Value / Share

$2.68

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-$44.45M

Total Cash

$36.54M

Debt to Equity

0.03

Issuance of Debt (TTM)

-$44.45M

Repayment of Debt (TTM)

-$44.45M